We assume that downregulation of WWOX is one of the critical events during the progression and development of IPMN, particularly at the late step of malignant transformation of pancreatic duct lesions, in addition to loss of SMAD4 expression. The gene discussed is SMAD4; the disease is pancreatic intraductal papillary-mucinous neoplasm.